Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder.
暂无分享,去创建一个
H. Miyake | S. Kamidono | S. Arakawa | I. Hara | S. Hara
[1] C. Petraki,et al. Prognostic significance of matrix metalloproteinases 2 and 9 in bladder cancer. , 2000, Anticancer research.
[2] O. Yoshida,et al. Role of matrix metalloproteinase-9 in the basement membrane destruction of superficial urothelial carcinomas. , 1999, The Journal of urology.
[3] H. Kanayama,et al. Prognostic values of matrix metalloproteinase‐2 and tissue inhibitor of metalloproteinase‐2 expression in bladder cancer , 1998 .
[4] H. Miyake,et al. Basic fibroblast growth factor regulates matrix metalloproteinases production and in vitro invasiveness in human bladder cancer cell lines. , 1997, The Journal of urology.
[5] D. Grignon,et al. High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer. , 1996, Cancer research.
[6] J. Foidart,et al. High level of MT‐MMP expression is associated with invasiveness of cervical cancer cells , 1996, International journal of cancer.
[7] W. Stetler-Stevenson,et al. Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.
[8] A. Strongin,et al. Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase , 1995, The Journal of Biological Chemistry.
[9] F. Sarkar,et al. Enhanced expression of tissue inhibitor of metalloproteinase‐2 (TIMP‐2) in the stroma of breast carcinomas correlates with tumor recurrence , 1994, International journal of cancer.
[10] A. Shinagawa,et al. Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). , 1994, Journal of cell science.
[11] Motoharu Seiki,et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells , 1994, Nature.
[12] A. Boag,et al. Increased expression of the 72-kd type IV collagenase in prostatic adenocarcinoma. Demonstration by immunohistochemistry and in situ hybridization. , 1994, The American journal of pathology.
[13] A. Hanby,et al. Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. , 1993, Cancer research.
[14] J. Nemeth,et al. TIMP-2, a growth-stimulatory protein from SV40-transformed human fibroblasts. , 1993, Experimental cell research.
[15] D. Miles,et al. Activity of type IV collagenases in benign and malignant breast disease. , 1993, British Journal of Cancer.
[16] J. Woessner,et al. Matrix metalloproteinases and their inhibitors in connective tissue remodeling , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[17] H. Miyake,et al. Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer. , 2000, Cancer research.
[18] I. Talbot,et al. Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. , 1996, Cancer research.